Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in Trials & Approvals

Ascentage to Begin China Phase III Trial of TKI for SDH-deficient GIST
Zymeworks’ HER2 Bispecific Under Review in China for Rare HER2 Cancers
Structure Posts Positive Obesity Drug Results; Raises $476 Million
SCG Cell Therapy Posts Solid Results for HBV T Cell Therapy
I-Mab’s Bispecific Antibody Joined by BMS’s PD-1 in Gastric Cancer Trial
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital